McKesson Secures $1.25B Apollo Investment in Medical-Surgical Unit Ahead of IPO
Event summary
- McKesson closed a $1.25 billion investment from Apollo Funds for a 13% stake in its Medical-Surgical Solutions (MMS) business on June 1, 2026.
- The deal values MMS at $13 billion in total enterprise valuation.
- McKesson retains majority ownership and operational control of MMS.
- The transaction is part of McKesson's plan to separate MMS into an independent, publicly traded company.
The big picture
This transaction marks a significant step in McKesson's strategy to streamline its portfolio and unlock value in its Medical-Surgical Solutions unit. The involvement of Apollo, a high-growth global alternative asset manager with $1.03 trillion in assets under management as of March 2026, underscores the strategic importance of MMS. The deal reflects broader industry trends of healthcare services companies leveraging private equity investments to facilitate spin-offs and enhance operational focus.
What we're watching
- IPO Timing
- Whether McKesson can complete the planned IPO of MMS on the currently contemplated timeline and terms.
- Strategic Growth
- How the Apollo investment will position MMS for long-term growth as an independent entity.
- Market Conditions
- The impact of broader economic and market conditions on the separation and IPO process.
Related topics